Topic
Chrysanthemum indicum
About: Chrysanthemum indicum is a research topic. Over the lifetime, 465 publications have been published within this topic receiving 4925 citations. The topic is also known as: Indian chrysanthemum.
Papers published on a yearly basis
Papers
More filters
Journal Article•
TL;DR: The volatile oil had resistant to five plant pathogenic fungi, and showed higher inhibitory activities especially against Sclerotinia sclerotiorum, its inhibition rate was 81.63% in density 500μg/mL of the volatile oil.
Abstract: The volatile oil from the stem and leaf of wild Chrysanthemum indicum was extracted by steam distillation,the chemical components of the volatile oil were separated and structurally identified by gas chromatography-mass spectrometry,and the antimicrobial activities of chemical components in the oils against the growth of five plant pathogenic fungi were evaluated by using growth rate methodA total of 32 compounds were identified in the volatile oil from the stem and leaf of wild Chrysanthemum indicum,the volatile oil had resistant to five plant pathogenic fungi,and showed higher inhibitory activities especially against Sclerotinia sclerotiorum,its inhibition rate was 8163% in density 500μg/mL of the volatile oil
1 citations
Patent•
11 Nov 2015
TL;DR: A pressure-reducing health tea which is prepared from the following raw materials in parts by weight: 3-4 parts of astragalus membranaceus, 5-8 parts of salvia miltiorrhiza, 10-12 parts of mulberries, 2-3 parts of appendicula terrestris, 4-5 parts of hawthorns, 4 -6 parts of dandelions, 5 − 8 parts of wolfberries, 3 − 4 parts of pueraria, 10 − 12 parts of raw sophora flower, 4 − 6
Abstract: The invention discloses pressure-reducing health tea which is prepared from the following raw materials in parts by weight: 3-4 parts of astragalus membranaceus, 5-8 parts of salvia miltiorrhiza, 10-12 parts of mulberries, 2-3 parts of appendicula terrestris, 4-5 parts of hawthorns, 4-6 parts of dandelions, 5-8 parts of wolfberries, 3-4 parts of pueraria, 10-12 parts of raw sophora flower, 4-6 parts of chrysanthemum indicum and 5-8 parts of corn stigma. The health tea disclosed by the invention contains various health Chinese herbal components, has the effects of reducing blood pressure, enhancing the immunity, resisting fatigue and the like and is easy to prepare and convenient to use.
1 citations
Patent•
30 Dec 2018
TL;DR: In this paper, a method for treating herpesvirus infections by administering a formulation comprising extracts of Rheum palmatum, Chrysanthemum indicum or Sanguisorba officinalis extracts or prevalent molecules therefrom with or without an antiviral agent, such as acyclovir and a pharmaceutically acceptable carrier.
Abstract: Disclosed is a formulation comprising at least two of Rheum palmatum, Chrysanthemum indicum and Sanguisorba officinalis extracts or prevalent molecules therefrom and a pharmaceutically acceptable carrier. Further disclosed is a formulation comprising one or more of Rheum palmatum, Chrysanthemum indicum and Sanguisorba officinalis extracts, or prevalent molecules therefrom in combination with acyclovir and a pharmaceutically acceptable carrier. Disclosed also is a method for treating herpesvirus infections by administering a formulation comprising extracts of Rheum palmatum, Chrysanthemum indicum or Sanguisorba officinalis extracts or prevalent molecules therefrom with or without an antiviral agent, such as acyclovir and a pharmaceutically acceptable carrier.
Patent•
14 Dec 2017
TL;DR: In this article, an anti-gout composition containing a mixture extract of Chrysanthemum indicum and Cinnamomum cassia as an active ingredient was proposed.
Abstract: The present invention relates to an anti-gout composition containing a mixture extract of Chrysanthemum indicum and Cinnamomum cassia as an active ingredient. It was verified that the xanthine oxidase inhibitory effect of the mixture extract of Chrysanthemum indicum and Cinnamomum cassia of the present invention was remarkable compared with the treatment with Chrysanthemum indicum and Cinnamomum cassia alone, and it was verified that the amount of uric acid in the urine was reduced by the administration with the mixture extract of Chrysanthemum indicum and Cinnamomum cassia of the present invention in an animal model. In addition, the mixture extract of Chrysanthemum indicum and Cinnamomum cassia of the present invention can be widely utilized in a gout-related industry since the mixture extract is an active ingredient derived from natural materials and thus the mixture extract is safe and the raw materials therefor are relatively easily supplied.
Patent•
15 Feb 2017
TL;DR: In this article, a chrysanthemum indicum extract for treatment of high blood pressure was presented, which can reduce the blood pressure of spontaneously hypertensive rats, and can be developed into drugs for treating hypertension.
Abstract: The invention discloses a chrysanthemum indicum extract for treatment of high blood pressure. The preparation method of the extract comprises: (a) employing a 60% ethanol solution to conduct heat reflux extraction on dried chrysanthemum indicum, combining the extracted liquid, and performing concentration to no alcohol taste, thus obtaining an ethanol extraction concentrated liquid; (b) diluting the ethanol extraction concentrated liquid obtained by step (a) with water, conducting extraction with petroleum ether, ethyl acetate and water saturated n-butanol in order, and carrying out pressure reduced concentration to obtain a petroleum ether extract, an ethyl acetate extract and a n-butanol extract respectively; (c) dissolving the n-butanol extract in water, performing filtering, using macroporous resin to enrich active ingredients, firstly using 8% ethanol to flush 12 column volumes to remove large polar components, then using 70% ethanol to elute 10 column volumes, collecting 70% eluent, and conducting pressure reduced concentration, thus obtaining the chrysanthemum indicum extract. The extract can reduce the blood pressure of spontaneously hypertensive rats, and can be developed into drugs for treatment of high blood pressure.